Company: APM
Filing Date: 2025-01-03
Form Type: 424B5
Source: 0001213900-25-000606
Chunk: 8

Company: Aptorum Group Ltd
Filing Date: 2025-01-03
Form: 424B5
Chunk 8
---
 the second quarter of 2023, the Company made a decision to streamline its operations by terminating clinic services and suspending non-lead R&D projects. This measure is aimed at optimizing the allocation of our resources and focusing our efforts on advancing our lead projects, which hold the most promise for commercial success and beneficial impact. This decision aligns with our commitment to enhance shareholder value and effectively drive our core objectives forward in the competitive landscape. In 2024, we determined it was best to focus all of our attention and resources on completing the potential merger with YOOV, as further explained below, and therefore paused the majority of our R&D activities during that time; following the termination of the related merger agreement with YOOV in the fourth quarter of fiscal 2024, we determined that searching for other business combination opportunities could maximize shareholder value, and our R&D activities remain suspended.

<div align='center'>S-2</div>

Proposed Merger and Subsequent Termination of Merger Agreement

On
March 1, 2024, we entered into an Agreement and Plan of Merger with YOOV Group Holding Limited, a company organized under the laws of
British Virgin Islands (“YOOV”). Upon consummation of the transactions contemplated by the Merger Agreement, a wholly-owned
subsidiary set up solely for purpose of this transaction under the laws of the British Virgin Islands (“Merger Sub”) would
merge with and into YOOV, with YOOV surviving the merger as a wholly-owned subsidiary of Aptorum (collectively, the “Merger”).
The existing YOOV shareholders and our shareholders were expected to own approximately 90% and 10%, respectively, of the outstanding shares
of the combined company immediately following the closing of the Merger. On October 25, 2024, the parties to the Merger Agreement entered
into a certain termination agreement (the “Termination Agreement”), pursuant to which the parties agreed to terminate the
Merger Agreement on the date thereof (the “Termination Date”), and the Merger Agreement shall be null and void and of no further
force or effect.

The
foregoing is only a brief description of the Merger and does not purport to be a complete description of the proposed terms of the Merger
and is qualified in its entirety by reference to the Merger Agreement and the Termination Agreement.

Potential Take-Over

On March 27, 2023, we entered
into a non-binding Letter of